Efficacy of Pirtobrutinib, a Highly Selective, Non-Covalent (Reversible) BTK Inhibitor in Richter Transformation: Results from the Phase 1/2 BRUIN Study

Authors :: William G. Wierda
David John Lewis
Paolo Ghia
Nirav N. Shah
Catherine C. Coombs
Chan Y. Cheah
Nicole Lamanna
Joanna M. Rhodes
Marc Hoffmann
Shuo Ma
Toby A. Eyre
Talha Munir
Manish R. Patel
Alvaro J. Alencar
Constantine S. Tam
John F. Seymour
Wojciech Jurczak
Ewa Lech-Marańda
Lindsey E. Roeker
Philip A. Thompson
Paolo B. Abada
Chunxiao Wang
Binoj Nair
Hui Liu
Donald E. Tsai
Anthony R. Mato
Source :: Blood. 140:846-849
Publication Year :: 2022
Publisher :: American Society of Hematology, 2022.

Tools